In clinical practice, monitoring GGT levels may aid in assessing the degree of oxidative stress and the risk of disease progression in NAFLD patients, particularly when liver biopsy is not feasible. Here, GGT1 is linked to metabolic dysfunction-associated steatotic liver disease.